Shatha Alqam
Biographic Data
| ID | 7968721 |
|---|---|
| NAME | Shatha Alqam |
| GIVEN NAMES | Shatha |
| FAMILY NAME | Alqam |
| SIGNATURE | ALQAM S |
| AFFILIATIONS | Hamad Medical Corporation |
| ORCID | 0009-0000-5418-9273 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Covid-19 disease outcomes in patients receiving clozapine versus other antipsychotics
Clozapine use was not associated with worse COVID-19 outcomes, supporting its relative safety during SARS-CoV-2 infection. These findings reassure clinicians regarding clozapine's continued use in treatment-resistant schizophrenia. However, the small clozapine sample size limits statistical power, warranting cautious interpretation and further research
No prominent works on this page.
Covid-19 disease outcomes in patients receiving clozapine versus other antipsychotics
Clozapine use was not associated with worse COVID-19 outcomes, supporting its relative safety during SARS-CoV-2 infection. These findings reassure clinicians regarding clozapine's continued use in treatment-resistant schizophrenia. However, the small clozapine sample size limits statistical power, warranting cautious interpretation and further research
Clozapine (1 works) · Confounding (1 works) · Internal Medicine (1 works) · Logistic regression (1 works) · Long-Term Effects of COVID-19 (1 works) · Medicine (1 works) · Odds ratio (1 works) · Psychiatry (1 works) · Retrospective cohort study (1 works) · Schizophrenia (object-oriented programming (1 works)